Board Meeting13 Nov 2026, 09:03 pm
Genesys International Approves Unaudited Financial Results and Grants ESOPs
AI Summary
Genesys International Corporation Ltd announced the outcome of its Board Meeting held on November 13, 2026. The Board approved the Unaudited Standalone & Consolidated Financial Results for the quarter and half year ended September 30, 2026. Additionally, the company granted 3,65,000 Employee Stock Options under the Genesys Employee Stock Option Scheme, 2022, with exercise prices ranging from Rs. 70 to Rs. 100 per equity share. The meeting commenced at 5:00 p.m. and concluded at 6:50 p.m.
Key Highlights
- Board approved unaudited standalone and consolidated financial results.
- Results are for the quarter and half year ended September 30, 2026.
- 3,65,000 Employee Stock Options were granted.
- ESOP exercise prices range from Rs. 70 to Rs. 100.
- Limited Review Report was issued by statutory auditors.
Price Impact
More from GENESYS